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Abstract
Background
Leprosy is a leading cause of preventable disability worldwide. Delay in diagnosis of
patients augments the transmission of infection, and allows progression of disease and
more severe disability. Delays in diagnosis greater than ten years have been reported in
Brazil. To reduce this delay, it is important to identify factors that hinder patients from pre-
senting to doctors, and those that delay doctors from diagnosing patients once they have
presented. This study aimed to explore factors associated with the delayed diagnosis of lep-
rosy in Brazil.
Methodology/ Principal Findings
This is an exploratory study using a self-constructed questionnaire delivered to patients
attending three leprosy referral clinics across three states in Brazil. Data were analysed to
determine associations between variables and the time taken for participants to present to
the health-service, and between variables and the time taken for doctors to diagnose partici-
pants once they had presented. Participants who suspected they had leprosy but feared
community isolation were 10 times more likely to wait longer before consulting a doctor for
their symptoms (OR 10.37, 95% CI 2.18–49.45, p = 0.003). Participants who thought their
symptoms were not serious had a threefold greater chance of waiting longer before consult-
ing than those who did (OR 3.114, 95% CI 1.235–7.856, p = 0.016). Forty-two point six per
cent of participants reported initially receiving a diagnosis besides leprosy. These had a
three times greater chance of receiving a later diagnosis of leprosy compared to those not
misdiagnosed or not given a diagnosis (OR 2.867, 95% CI 1.288–6.384, p = 0.010).
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Conclusions/ Significance
This study implies a need for patient education regarding leprosy symptoms and the reduc-
tion of stigma to encourage patients to present. The high rate of misdiagnosis reported sug-
gests a need to increase clinician suspicion of leprosy. Further education regarding disease
symptoms in medical school curriculums may be advisable.
Author Summary
Leprosy is caused by a bacterium that affects people’s nerves, giving rise to deformities.
Leprosy largely affects the poor, and many people around the world are disabled due to
leprosy. The deformities that the disease causes are largely preventable through early
detection of the disease. In countries such as Brazil, where high rates of leprosy cases still
exist, this disease remains a public health issue. However, long delays in the diagnosis of
leprosy patients have been reported. In this study we observed that many patients were
ignorant to the early symptoms of leprosy, and that the negative image surrounding lep-
rosy within communities can hinder patients from seeking treatment due to the fear of
being isolated. In addition, we noted that doctors often do not reach a conclusive diagnosis
of leprosy promptly. This misdiagnosis appears to be contributing to the overall delay in
the diagnosis of leprosy patients in areas of Brazil. Although more research exploring this
subject should be conducted, this study highlights a possible need for further educational
interventions for both patients and doctors.
Introduction
Leprosy (Hansen’s disease) is one of the world’s Neglected Tropical Diseases and is recognised
as ‘a disease of the poor’[1–3]. It is an infectious disease that is caused by the bacteriumMyco-
bacterium leprae. This bacterium affects peripheral nerves and gives rise to deformities such as
muscle wasting and injuries over anaesthetised areas of the body [2,4,5]. Leprosy is a leading
cause of preventable disability, leaving 3 million people disabled worldwide [1]. Although
much work has been done in recent years to eliminate the disease, leprosy remains endemic in
nine counties, including Brazil. Brazil contributed 33 955 new cases in 2011, 16% of all new reg-
istered global cases, second only to India [6]. Furthermore, Brazil was not predicted to achieve
the WHO’s ‘Final push’ goal for 2015. This was to reduce the number of new cases with grade
2 disability that were detected in 2010 by 35% (grade 2 disability is defined as visible damage or
deformity) [7–9].
In order to break the cycle of transmission and reduce the number of new cases detected
with physical deformity, it is essential to diagnose and treat patients early, before these injuries
occur [5,8].
However, significant delays in diagnosis of leprosy have been reported in Brazil [10, 11].
These delays of up to 10 years, are unexpectedly even longer than those observed in some non-
endemic countries [11]. The only study found in the literature search which explored reasons
for the delay in diagnosis in Brazil, was an English language study from 1997 [10]. However,
this study yielded no significant results and was limited to a small sample size of 40 partici-
pants; leaving much further need for research in this area.
We therefore conducted our study with the aim of exploring factors that contribute to the
overall delay in diagnosis of leprosy. Such factors can be divided into two categories: those
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contributing to ‘patient delay’ (defined as the time between symptom onset and patients con-
sulting a medical doctor) and those contributing to ‘health-system delay’ (defined as the time
between first consulting a medical doctor and receiving a diagnosis of leprosy). Our study
aimed to explore patient and health system delays separately; interested in identifying whether
the delay in diagnosis of leprosy is associated with patients not presenting to the health service
early enough or whether diagnosis is being delayed by the health service itself.
Literature from other countries has largely focused on patient delay. Demographic variables
such as distance from the nearest health clinic and patients’ highest level of education were
found to be associated with delay in China and India [12,13]. Additionally, leprosy patients
have been found to prefer visiting traditional healers, rather than trained medical doctors
[12,14,15]. As every society considers life and disease in different ways, it is essential to study
similar questions regarding this delay within Brazil [16]. By exploring these demographic fac-
tors we can identify potential target groups for future public health interventions. Furthermore,
the fear and stigma associated with leprosy in both endemic and non-endemic countries has
been suggested to prevent patients from presenting to the health service for their symptoms
[17–23]. This study aims to explore the effect of stigma through quantitative methods.
Leprosy care was integrated into primary care in Brazil in the year 2000 [24]. Although this
may have encouraged patients to seek treatment, it is possible that clinical expertise regarding
leprosy has declined. Health professionals may require more education regarding the early
symptoms of leprosy, as has been suggested for tuberculosis [25]. Therefore, this study also
aims to explore clinician suspicion of leprosy [13].
With previous literature in mind, this study was performed focusing on demographic vari-
ables, stigma, traditional healers, clinical examination and misdiagnosis, with the secondary
aim of identifying factors that motivate patients to consult a medical doctor for their symptoms
[13].
Methods
Setting
The primary setting for this research was Lauro de Souza Lima Institute (ILSL)–São Paulo—
Brazil. This is a leprosy research and referral clinic, a governmental institute under the ministry
of public health. ILSL serves a population of 350, 000 patients from all five geographical regions
of Brazil. From here we visited two other referral centres to gain a larger sample size: Sinop
Reference Centre for Leprosy and Tuberculosis (CRTHS)—Mato Grosso and Dourados Refer-
ence Centre for Leprosy and Tuberculosis (CRTHD)—Mato Grosso do Sul [26–28]. Participants
attending these referral clinics during the study recruitment period were therefore not neces-
sarily diagnosed there. Data collection and the study method were standardised throughout the
three sites, with the same measurement tools and researchers in each. Referral clinics were cho-
sen instead of primary care clinics, as the bases for this research in order to recruit sufficient
numbers in the allocated time frame.
Recruitment of participants
ILSL serves outpatients, inpatients, and residents of the former leprosy colony. All inpatients
and residents were asked to participate. All leprosy patients attending outpatient appointments
were also approached. Clinicians caring for these patients were first asked if researchers could
inform their patients of the study.
Fifty-six participants were recruited from ILSL: 43 outpatients, 7 inpatients and 6 residents.
All patients attending outpatient appointments at CRTHS and CRTHD were also asked to par-
ticipate. Forty-two outpatients were recruited from Sinop and 24 from Dourados.
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Ethical considerations
Ethical approval from University of Birmingham BMedSc Population Sciences and Humanities
internal ethics review and the Committee for Ethics in Research, Instituto Lauro de Souza
Lima, Bauru, Brazil were obtained before commencing the study.
Adults previously diagnosed with leprosy either clinically or by laboratory testing were
included in our study. Informed consent was gained from all participants. Written consent was
gained from literate participants and verbal consent from illiterate participants. For literate par-
ticipants unable to sign due to hand or finger deformities, consent was obtained via fingerprint.
Prior approval for documenting oral and consent by fingerprint was obtained from the internal
review board. After consulting with a member of the Brazilian Committee for ethics and medical
director of ILSL, it was deemed culturally appropriate to accept the adult age for leprosy research
to be 15 and over [8, 29]. Participants between 15 and 18 years of age consented for themselves,
as they were competent and so consent was not sought from parents on their behalf.
Exclusion criteria applied
1. Children below the age of 15 (as is culturally appropriate in Brazil) [8,29].
2. Adults lacking capacity to consent.
3. Patients diagnosed less than one month prior to their appointment. (To avoid possibly dis-
tressing newly diagnosed patients, who were still coming to terms with their diagnosis, by
asking them to discuss events surrounding their diagnosis.)
4. Patients experiencing recent, serious life events (e.g. bereavement) or serious health problems
at the time of interview (e.g. leprosy reaction). (This was done as a sensitive precaution to
ensure participants were both physically and mentally able to provide accurate information.)
Study design
This exploratory study used a self-constructed, quantitative questionnaire (S1 Appendix),
which was delivered to participants over a seven-week recruitment period in February/March
2014. Literate participants completed the questionnaire themselves, whilst an interpreter deliv-
ered the questionnaire verbally to illiterate participants and those unable to write due to pain
or hand deformities.
As this was an explorative study, maximum feasibility sampling was used. This study was
part of a wider study that involved co-researchers.
Measurement tool
No validated questionnaire relating to the subject was available; therefore, questions were for-
mulated based on findings from previous qualitative and quantitative studies in Brazil and else-
where [11–15,30–32]. The questionnaire was translated into Portuguese and piloted on
consenting patients at ILSL. Issues with understanding were identified and the questionnaire
adjusted accordingly.
In the questionnaire, participants were asked to report the time elapsed between first noting
leprosy symptoms and visiting a medical doctor for these symptoms. This was labelled as
patient delay. Participants were also asked to report the time that elapsed between their first
visit to a medical doctor and them receiving a diagnosis of leprosy/Hansen’s disease. This was
labelled as health system delay. Both time frames were recorded as ordinal variables to assist
participant recall.
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Other questions in the questionnaire consisted of variables potentially associated with
patient delay and health-system delay. The questionnaire consisted of three sections:
1. Demographics: age, gender, employment, education, income and marital status.
2. Variables specific to patient delay: first symptom, age at symptom onset, who was
informed about their symptoms and reason for waiting before consulting a doctor.
3. Variables specific to health-system delay: region, health centre funding, symptoms at presen-
tation, number of symptoms, misdiagnosis and clinical examinations. The examinations consid-
ered in this study were those pertaining to the clinical diagnosis of leprosy. These included
examination of the skin, sensory testing, nerve palpation and a skin smear/ biopsy sample.
Demographic variables and those specific to patient delay were analysed to determine asso-
ciations of these factors with patient delay. Demographic variables and those specific to health
system delay were analysed to determine associations with health-system delay.
All data were collected from the questionnaire. Where there was missing responses to the
questionnaire, medical records were consulted to obtain this information if documented. All
data obtained were anonymised.
Statistical analysis
All data were treated and analysed using software Statistical Package for Social Sciences (SPSS)
version 21.0.
Participants were grouped according to their responses to the questionnaire. Univariate
analyses for patient delay and health system delay were conducted through Mann-Whitney U
tests for binary predictor variables e.g. gender, Kruskal-Wallis tests for categorical predictor
variables with more than two groups e.g. employment and spearman’s rank correlation for
ordinal and continuous predictors e.g level of education and age at symptom onset, respec-
tively. Multivariate analysis was conducted by ordinal regression and odds ratios calculated.
A p value of< 0.10 in the univariate analysis was the criterion for including variables in the
multivariate analysis. After selection of variables for the regression models, those that lost sig-
nificance were excluded. The statistical significance level considered for multivariate analyses
was 5%, p<0.05.
Regarding the secondary aim of identifying factors that motivate patients to consult,
patients were grouped according to their questionnaire responses to the question ‘What
encouraged you to visit a medical doctor?’ Proportions of participants selecting each response
were calculated.
Sample description
After applying the exclusion criteria, 122 patients consented to participate in the study: 83 men
and 39 women (Table 1). The age range for this sample was 20–86 years with a mean age of
48.9 years.
Results
Participants reported visiting health centres in both endemic and non-endemic regions of Bra-
zil when they first consulted a doctor about their symptoms. Participants presented to doctors
in four out of the five geographical regions of Brazil (Table 1). Sixty-six participants (45.3%)
presented in the endemic central-west region of Brazil. Both patient and health-system delays
were found to be independent of region in the univariate analyses using Kruskal-Wallis tests
(X2 = 0.262, p = 0.967 and X2 = 4.982, p = 0.173 respectively).
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Patient delay
One hundred and twenty one participants, (99.2%), reported presenting to a medical doctor
within 5 years of symptom onset and no patient delay exceeded 10 years (Table 3).
Table 1. Frequencies and percentages for gender, grade of disability and region of participants’ first
consultation with a medical professional.
Frequency (n) Percentage (%)
Gender
Male 83 68.0
Female 39 32.0
Region of ﬁrst consultation
Central-west 66 54.1
Southeast 43 27.3
Northeast 5 4.1
South 5 4.1
Missing 3 2.5
Income was classiﬁed according to the Brazilian institute of geography and statistics (IBGE), where three
minimum salaries equals R$ 2,172, which is equivalent to £587 (Table 2) [33].
doi:10.1371/journal.pntd.0004542.t001
Table 2. Frequencies and percentages of participants’ personal and household incomes and highest
level of education.
Frequency (n) Percentage (%)
Personal income
No income 9 7.38
 1 minimum salary 48 39.34
1–2 minimum salaries 38 31.15
2–3 minimum salaries 15 12.30
3–4 minimum salaries 4 3.28
4–5 minimum salaries 2 1.64
> 5 minimum salaries 3 2.46
Missing 3 2.46
Household income
 1 minimum salary 24 19.67
1–2 minimum salaries 37 30.33
2–3 minimum salaries 30 40.98
3–4 minimum salaries 14 11.48
4–5 minimum salaries 10 8.20
> 5 minimum salaries 6 4.92
Missing 1 0.82
Highest level of Education
Never studied 6 4.92
Pre-school 9 7.38
Elementary school 58 47.54
Secondary school 16 13.11
High school 28 22.95
Higher education 5 4.10
doi:10.1371/journal.pntd.0004542.t002
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In the univariate analysis, patient delay was found to be independent of demographic vari-
ables (e.g. age, region and income) (p 0.10). Seven variables were found to be associated with
patient delay, in univariate analysis (p< 0.1) and were included in the multivariate ordinal
regression model (Table 4). Four factors remained significant at p< 0.05. Patient delay was
found to have reduced over time, with the odds of participants presenting quicker, being 25.4%
higher, for each decade that has passed since the 1930s (OR 0.746 95% CI 0.593–0.939,
p = 0.013). For participants who thought their symptoms were due to leprosy but feared they
would be isolated from their community, the odds of them waiting longer before consulting
was ten times higher than those who did not fear isolation (OR 10.37, CI 2.18–49.45,
p = 0.003). Fifty-five participants, (45.1%), said they waited before consulting because they did
not believe their symptoms were serious. The odds of them waiting longer was three times
higher compared to those who did consider their symptoms serious (OR 3.114, 95% CI 1.235–
7.856, p = 0.016). Participants who visited a traditional healer before a qualified medical doctor
Table 3. Frequencies and cumulative percentages of presentation time and diagnosis time for participants in this sample.
Presentation time (symptom
onset to doctor visit)
Frequency
(n)
Cumulative
percentage (%)
Diagnosis time (ﬁrst
consultation to diagnosis)
Frequency
(n)
Cumulative
percentage (%)
0–2 weeks 46 37.7 0–2 weeks 40 32.8
15 days– 31 days 16 50.8 15 days– 31 days 18 47.5
1–3 months 18 65.6 1–3 months 7 53.3
3–6 months 7 71.3 3–6 months 10 61.5
6–12 months 15 83.6 6–12 months 16 74.6
1–2 years 10 91.8 1–2 years 9 82.0
3–5 years 9 99.2 3–5 years 11 91.0
6–10 years 1 100 6–10 years 6 95.9
>10 years 0 100 >10 years 5* 100
Total 122 100 Total 122 100
* Diagnosis time ranged up to 41 years for one participant.
doi:10.1371/journal.pntd.0004542.t003
Table 4. Ordinal and logistic regressionmodels for predictors of longer presentation time and delayed presentation respectively.
Predictors of longer patient delay, Pseudo R-square = 0.368
Variable Coefﬁcient Standard error
(S.E).
z P
value
Odds ratio (OR)
Exp(B)
95% Conf.
Interval for
Exp(B)
Lower Upper
*Feared isolation 2.339 0.7969 8.614 .003* 10.371 2.175 49.448
*Decade of ﬁrst Symptom (earliest decade (1930s) as
reference)
-.293 0.1174 6.225 .013* 0.746 .593 .939
*Thought symptoms were not serious 1.136 0.4721 5.790 .016* 3.114 1.235 7.856
*Visited a natural healer 2.340 1.1493 4.147 .042* 10.386 1.092 98.784
Expected symptoms would disappear .871 1.831 3.159 .076 2.389 .914 6.241
Told no-one about symptoms .588 0.4680 1.578 .209 1.800 .719 4.505
Had no pain .443 0.4585 .933 .334 1.557 .634 3.825
All variables included in these regression models were those, which were found to be signiﬁcantly associated with presentation time and delayed
presentation at p < 0.1 in univariate analysis.
* Variables achieving signiﬁcance at p = 0.05 in regression
doi:10.1371/journal.pntd.0004542.t004
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had 10 times higher odds of waiting longer before consulting a trained medical doctor than
those who did not (OR 10.386, CI 1.092–98.784, p = 0.042).
Health system delay
Five participants reported receiving a diagnosis of leprosy more than 10 years after consulting
a medical doctor about their symptoms. Health-system delay ranged up to 41 years for one par-
ticipant (Table 3).
No statistically significant correlation between the number of presenting symptoms and
health-system delay (rs 0.036, p = 0.698) was found in univariate analysis with Spearman’s
rank correlation. In the multivariate analyses, health-system delay was found to be independent
of demographic variables (e.g. age and region of consultation) (p 0.05).
Reported misdiagnosis remained statistically significantly associated with a longer health-
system delay in multivariate analysis (Table 5). The likelihood of misdiagnosed patients receiv-
ing a later diagnosis was nearly three times higher than those who were not misdiagnosed
(those who were either correctly diagnosed or not given any diagnosis on their first visit) (OR
2.867, 95% CI 1.288–6.384, p = 0.01). The number of examinations performed by doctors on
the participants’ first consultation was associated with health system delay. For every additional
examination performed, the odds of a patient receiving a quicker diagnosis of leprosy was 46%
(OR 0.539, CI 0.393–0.739). The only presenting symptom associated with health system delay
was hypo-pigmented, insensitive skin lesions. Patients presenting with insensitive skin lesions
had a 55% higher chance of being diagnosed quicker than those who did not present with this
symptom (OR 0.463, CI 0.222–0.964, p = 0.039).
Fifty-two participants (42.6%) reported being misdiagnosed. Of these, 17.3% reported being
misdiagnosed with skin allergy and 13.5% with other skin conditions such as ringworm and
furunculosis. Another 13.5% reported a diagnosis of rheumatism and 9.6% of vascular condi-
tions including infarct (occlusion of blood supply).
Motivators to consulting
The majority of participants answered that they first visited a doctor, due to their symptoms
worsening, (48.4%), or persisting (20.5%).
Table 5. Ordinal and logistic regressionmodels for predictors of longer diagnosis time and delayed diagnosis respectively.
Predictors of longer health-system delay, Pseudo R-square = 0.445
Variable Coefﬁcient Standard error
S.E.
z P
value
Odds ratio OR Exp
(B)
95% Conf.
Interval for
Exp(B)
Lower Upper
*Number Of Exams (0 as reference) -0.618 0.1609 14.758 <0.001 0.539 0.393 0.739
*Misdiagnosed -1.053 0.4083 6.656 0.010 2.867 1.288 6.384
*Presented with insensitive skin lesion 0.770 0.3740 4.240 0.039 0.463 0.222 0.964
Gender (female as reference) -0.695 0.3752 3.434 0.064 0.499 0.239 1.041
Decade of presentation (earliest decade 1940 as
reference)
-0.175 0.1068 2.675 0.102 0.840 0.681 1.035
Referred to another doctor -0.511 0.3777 1.828 0.176 1.667 0.795 3.494
Examined 0.256 0.5231 0.240 0.624 0.774 0.278 2.158
All variables included in these regression models were those, which were found to be signiﬁcantly associated with diagnosis time and delayed diagnosis
at p < 0.1 in univariate analysis.
*Variables achieving signiﬁcance at p = 0.05 in the regression mode
doi:10.1371/journal.pntd.0004542.t005
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Discussion
The aims of this study were achieved as we identified factors associated with patient and health
system delays that could be contributing to the overall delayed diagnosis of leprosy in Brazil.
The principal factors found to be associated with patient delay were participants who feared
community isolation and those who visited a traditional healer. The odds of each waiting lon-
ger before consulting a medical doctor was ten times higher compared to those who did not.
However, these only constituted a small proportion of participants. Many more participants
delayed because they did not think their symptoms were serious. The odds of these waiting lon-
ger before consulting was three times greater compared to those who did believe their symp-
toms were serious. These three factors explained 37.0% of the variance in patient delay and
therefore, could help reduce patient delay, if targeted.
These findings indicate that stigma towards leprosy sufferers remains despite the availability
of a cure, even in endemic regions [12,13]. Fear of isolation was a strong predictor of longer
patient delay, implying that community isolation still exists in Brazil, despite compulsory con-
finement ending in 1962. Some patients seem to conceal their symptoms and delay in seeking
treatment due to fear of social exclusion [32]. Yet only 8.2% of participants delayed due to the
fear of isolation. This is likely due to governmental efforts to abolish this stigma; by integrating
leprosy care into primary care and changing its name from leprosy to Hansen’s disease. None-
theless, political commitment to diminish the stigma surrounding the disease must persist
[13,34]. Through national health programmes, the public should be informed that leprosy is
curable and that the disability, which has instigated much fear is preventable [14,31,35].
Many patients appear to still be ignorant regarding leprosy symptoms. Nearly half of the
participants in this study (45.1%) waited before consulting a doctor because they did not
believe their symptoms were serious. This was supported by the observation that 68.9% of par-
ticipants consulted a doctor because their symptoms either persisted or worsened. These find-
ings support research in India and suggest an important need to educate patients regarding the
early symptoms of leprosy, in order to encourage them to present early [1,5,13]. As leprosy is a
disease of the poor and literacy rates are low among this population in Brazil, it could be useful
to incorporate graphics or animations into patient education tools from primary care clinics or
even in public areas such as bus stops, where educational posters could be displayed [3,36].
Visiting a traditional healer was not found to be as clinically relevant as found in Nepal,
Nigeria and Ethiopia, in contributing to patient delay [14,37,38]. Although statistically signifi-
cant, only a small proportion (2.5%) of participants in this study reported visiting a traditional
healer. This percentage may be higher in poorer, more rural areas where access to healthcare is
limited; future research should be done in such areas to explore this further [28].
The principal association with longer health system delays was found to be patient reported
misdiagnosis. Higher numbers of clinical examinations (pertaining to leprosy diagnosis) per-
formed by doctors were associated with a quicker diagnosis, whilst patients presenting to a doc-
tor with an insensitive skin lesion were diagnosed quicker than those without this symptom.
These factors together explain 44.5% of the variance in health-system delay. Acting on these
factors could help to reduce the health-system delay in leprosy diagnosis.
High rates of misdiagnosis of leprosy patients have previously been reported in Brazil where
32.5% of participants were misdiagnosed [10]. Similarly, in this study, 42.6% reported being
misdiagnosed. Participants commonly reported being misdiagnosed with conditions such as
rheumatism and skin allergy. This possible lack in clinician suspicion could be explained by the
decentralisation of leprosy care in Brazil. However, despite the gradual decline in the incidence
of leprosy cases in Brazil, health professionals should expect to encounter leprosy patients dur-
ing their practice, especially in endemic regions. Medical students must also continue to be
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educated regarding leprosy symptoms at university [28]. The only symptom associated with a
quicker diagnosis was the cardinal symptom of an insensitive skin lesion. Health system delay
was found to be independent to the number of symptoms patients presented to doctors with.
Clinicians may therefore benefit from further education regarding leprosy symptoms other
than insensitive skin lesions. Primary health clinics could trial various educational tools to
assist doctors in differentiating between leprosy symptoms and those of other diseases e.g.
rheumatism and skin allergy. This could be done through Internet learning where possible or
education leaflets in resource poor settings. Research could be done to determine their effec-
tiveness at increasing clinicians’ suspicions of leprosy and reducing health system delays in
diagnosis. In light of these findings, future qualitative and quantitative research could also
explore primary care clinicians' knowledge of leprosy and its symptoms.
Limitations of this study include accuracy of recall and social acceptability bias. Although
measures were taken within the questionnaire to assist participant recall, data collection largely
depended on participant reported information. Furthermore, a sizeable proportion of partici-
pants were functionally illiterate and required verbal questionnaire delivery. These responses
may have been influenced by social acceptability bias with participants reporting shorter
patient delays. Nevertheless, as high illiteracy rates occur among leprosy patients, it was neces-
sary to include illiterate participants in this study in order to provide a more representative
sample of leprosy patients [3,39].
This study was limited to three referral centres. This sample is likely to differ from simple
leprosy cases, which are dealt with in the community and results from this study may not be
generalizable throughout the country. Although delays were found to be independent of region
in this study, previous research has indicated that reason for delay can vary between regions of
the same country, with some areas seeing long health system delays whilst others seeing longer
patient delays [30]. Few participants in this study had presented to health centres in the rural,
endemic north and northeast regions of Brazil which have reported some of the highest rates of
leprosy but low availability of human recourses and limited access to health care [28, 40].
Therefore similar research exploring the delay in diagnosis of leprosy in these regions would be
of great value.
In conclusion, this study highlights the potential need for further patient education regard-
ing disease symptoms and the reduction of stigma to encourage patients to seek earlier medical
care. Furthermore, this study supports the high rates of misdiagnosis amongst leprosy patients
reported elsewhere in Brazil and suggests the need for greater education of primary care clini-
cians with regards to leprosy symptoms. Exploring primary care clinicians’ knowledge of dis-
ease symptoms and trialling educational tools could assist in reducing the delay in diagnosis
and continued transmission of leprosy in Brazil. Finally, similar research to this study should
explore the delay in diagnosis of leprosy in northern regions of Brazil.
Supporting Information
S1 Appendix. Quantitative questionnaire: Data collection tool. The questionnaire consists
of three sections: 1. Demographics: age, gender, employment, education, income and marital
status. 2. Variables specific to patient delay: first symptom, age at symptom onset, who was
informed about their symptoms and reason for waiting before consulting a doctor. 3. Variables
specific to health-system delay: region, health centre funding, symptoms at presentation, num-
ber of symptoms, misdiagnosis and clinical examinations. The examinations considered were
those pertaining to the clinical diagnosis of leprosy and included examination of the skin, sen-
sory testing, nerve palpation and a skin smear/ biopsy sample.
(PDF)
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